Davis R M Inc. Sells 490 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Davis R M Inc. decreased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 9.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,611 shares of the medical device company’s stock after selling 490 shares during the quarter. Davis R M Inc.’s holdings in Cooper Companies were worth $424,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Fulton Bank N.A. lifted its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after purchasing an additional 109 shares during the last quarter. Torray Investment Partners LLC boosted its holdings in Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. grew its stake in shares of Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after acquiring an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares in the last quarter. Finally, Greenleaf Trust raised its position in shares of Cooper Companies by 5.0% in the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after purchasing an additional 139 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

NASDAQ COO opened at $81.03 on Wednesday. The stock has a market capitalization of $16.17 billion, a price-to-earnings ratio of 41.55, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 1-year low of $78.43 and a 1-year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The business’s fifty day moving average price is $91.93 and its 200-day moving average price is $99.25.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

Several analysts recently commented on the stock. Piper Sandler reissued an “overweight” rating and set a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Finally, Wells Fargo & Company lifted their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $111.89.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.